Cashu
BioMarin Pharmaceutical: Positioned for Growth Amid Market Optimism and Innovative Therapies
3 days ago
Stocks
Health Care
bmrn
Biomarin Pharmaceutical
BMRN
-0.48 (-0.89%)
54.205
USD
At close at Jun 25, 18:36 UTC
Latest Biomarin Pharmaceutical News
cnbc.com
6 stocks to buy for the second half, according to Wall Street analysts
3 days ago
benzinga.com
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
13 days ago
cnbc.com
Cramer's Lightning Round: Union Pacific is a buy
14 days ago
benzinga.com
A Look Into Biomarin Pharmaceutical Inc's Price Over Earnings
about 2 months ago
businesswire.com
Orphan Drugs Strategic Research Report 2024-2030: A Beacon of Hope for Patients with Rare Diseases - Market to Reach $394.7 Billion by 2030 - ResearchAndMarkets.com
5 months ago
businesswire.com
CatalYm Appoints Scott Clarke CEO as Company Initiates Global Phase 2b Clinical Development Program for Visugromab
6 months ago
businesswire.com
Biocom California Appoints New Members to its Board of Governors
.jpg)
8 months ago
benzinga.com
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
9 months ago
finance.yahoo.com
High Growth Tech Stocks To Watch For Future Potential
9 months ago
finance.yahoo.com
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
9 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.